Disparities in the presence of driver mutations and response to tyrosine kinase inhibitors in young patients with lung cancer

被引：0
|
作者：
Edwards, Kyle
Rose, Brandon
Lopes, Gilberto
Rodriguez, Estelamari
Olazagasti, Coral
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-A106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A106
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Cardiovascular Complications by EGFR Tyrosine Kinase Inhibitors in Patients with Lung Cancer
    Kimura, Koichi
    Morita, Hiroyuki
    INTERNATIONAL HEART JOURNAL, 2021, 62 (05) : 949 - 951
  • [12] MODERN VECTOR IN TREATMENT OF PATIENTS WITH LUNG CANCER: TYROSINE KINASE INHIBITORS IN EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
    Smorodska, O. M.
    Moskalenko, Yu, V
    Vynnychenko, I. O.
    Vynnychenko, O., I
    Kostuchenko, V. V.
    MEDICNI PERSPEKTIVI, 2021, 26 (02): : 4 - 11
  • [13] Liquid biopsy for screening of driver mutations in EGFR gene: Personalized medicine for use tyrosine kinase inhibitors in non-small cell lung cancer patients
    Cirillo, Priscila D. R.
    Lopes, Natalia P.
    Bustamante, Carolina
    Morais, Agatha A.
    Viana, Natalia L.
    Portella, Camila S.
    Mateo, Elvis C. C.
    Freire, Maira C. M.
    Zalis, Mariano G.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 66 - 67
  • [14] Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
    Murray, Samuel
    Karavasilis, Vasilios
    Bobos, Mattheos
    Razis, Evangelia
    Papadopoulos, Savvas
    Christodoulou, Christos
    Kosmidis, Paris
    Fountzilas, George
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [15] Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of non-small cell lung cancer patients.
    Marchetti, Antonio
    Palma, John F.
    Felicioni, Lara
    De Pas, Tommaso Martino
    Chiari, Rita
    Del Grammastro, Maela
    Filice, Giampaolo
    Ludovini, Vienna
    Brandes, Alba Ariela
    Chella, Antonio
    Malorgio, Francesco
    Guglielmi, Flavio
    De Tursi, Michele
    Santoro, Armando
    Crino, Lucio
    Buttitta, Fiamma
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [16] Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
    Samuel Murray
    Vasilios Karavasilis
    Mattheos Bobos
    Evangelia Razis
    Savvas Papadopoulos
    Christos Christodoulou
    Paris Kosmidis
    George Fountzilas
    Journal of Experimental & Clinical Cancer Research, 31
  • [17] Lung Cancer in Young Patients: The Importance of Assessing Driver Mutations and Treatment Strategies
    Yuichi Adachi
    Kinnosuke Matsumoto
    Takatoshi Enomoto
    Lung, 2020, 198 : 425 - 426
  • [18] Lung Cancer in Young Patients: The Importance of Assessing Driver Mutations and Treatment Strategies
    Adachi, Yuichi
    Matsumoto, Kinnosuke
    Enomoto, Takatoshi
    LUNG, 2020, 198 (02) : 425 - 426
  • [19] Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
    Kobayashi, Susumu
    Canepa, Hannah M.
    Bailey, Alexandra S.
    Nakayama, Sohei
    Yamaguchi, Norihiro
    Goldstein, Michael A.
    Huberman, Mark S.
    Costa, Daniel B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) : 118 - 122
  • [20] Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer
    Hunter, S.
    Nickless, G.
    Ghosh, S.
    Lal, R.
    Merrick, S. A.
    Montes, A.
    Smith, D.
    Spicer, J.
    Karapanagiotou, E.
    LUNG CANCER, 2017, 103 : S34 - S35
12345